Literature DB >> 3040246

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.

B A Conley, J Hornedo, J Abrams, M Eisenberger, D Hiponia, J Aisner, D A Van Echo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3040246

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Authors:  C Rose; T E Lad; L J Kilton; J Schor; S T Rosen; A H Rossof; R R Blough; C M Johnson
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

2.  Phase II study of 4'-iodo-4'-deoxydoxorubicin in non-resectable non-small-cell lung cancer.

Authors:  J B Sørensen; L Stenbygaard; L Drivsholm; P Dombernowsky; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.